Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/HCR.0000000000000643 http://scihub22266oqcxt.onion/10.1097/HCR.0000000000000643 34461621!8436146!34461621     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34461621&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Cardiopulm+Rehabil+Prev 2021 ; 41 (5): 308-314 Nephropedia Template TP {{tp|p=34461621|t=2021. Financial Analysis of Cardiac Rehabilitation and the Impact of COVID-19 |pdf=|usr=}}{{34461621}} gab.com Text Financial Analysis of Cardiac Rehabilitation and the Impact of COVID-19 JO: J Cardiopulm Rehabil Prev http://www.kidney.de/pget.php?&tw=1&pmid=34461621 #FOAvip PURPOSE: Provision of phase 2 cardiac rehabilitation (CR) has been directly impacted by coronavirus disease-19 (COVID-19). Economic analyses to date have not identified the financial implications of pandemic-related changes to CR. The aim of this study was to compare the costs and reimbursements of CR between two periods: (1) pre-COVID-19 and (2) during the COVID-19 pandemic. METHODS: Health care costs of providing CR were calculated using a microcosting approach. Unit costs of CR were based on staff time, consumables, and overhead costs. Reimbursement rates were derived from commercial and public health insurance. The mean cost and reimbursement/participant were calculated. Staff and participant COVID-19 infections were also examined. RESULTS: The mean number of CR participants enrolled/mo declined during the pandemic (-10%; 33.8 +/- 2.0 vs 30.5 +/- 3.2, P = .39), the mean cost/participant increased marginally (+13%; $2897 +/- $131 vs $3265 +/- $149, P = .09), and the mean reimbursement/participant decreased slightly (-4%; $2959 +/- $224 vs $2844 +/- $181, P = .70). However, these differences did not reach statistical significance. The pre-COVID mean operating surplus/participant ($62 +/- $140) eroded into a deficit of -$421 +/- $170/participant during the pandemic. No known COVID-19 infections occurred among the 183 participants and 14 on-site staff members during the pandemic period. CONCLUSIONS: COVID-19-related safety protocols required CR programs to modify service delivery. Results demonstrate that it was possible to safely maintain this critically important service; however, CR program costs exceeded revenues. The challenge going forward is to optimize CR service delivery to increase participation and achieve financial solvency. Twit Text FOAVip Financial Analysis of Cardiac Rehabilitation and the Impact of COVID-19 ????J Cardiopulm Rehabil Prev http://www.kidney.de/pget.php?&tw=1&pmid=34461621 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34461621 #FOAvip English Wikipedia <ref>{{Cite pmid|34461621}}</ref> Financial Analysis of Cardiac Rehabilitation and the Impact of COVID-19 #MMPMID34461621 Melbostad HS; Savage PD; Mahoney K; Gaalema DE; Ades PA; Shepard DS J Cardiopulm Rehabil Prev 2021[Sep]; 41 (5): 308-314 PMID34461621show ga PURPOSE: Provision of phase 2 cardiac rehabilitation (CR) has been directly impacted by coronavirus disease-19 (COVID-19). Economic analyses to date have not identified the financial implications of pandemic-related changes to CR. The aim of this study was to compare the costs and reimbursements of CR between two periods: (1) pre-COVID-19 and (2) during the COVID-19 pandemic. METHODS: Health care costs of providing CR were calculated using a microcosting approach. Unit costs of CR were based on staff time, consumables, and overhead costs. Reimbursement rates were derived from commercial and public health insurance. The mean cost and reimbursement/participant were calculated. Staff and participant COVID-19 infections were also examined. RESULTS: The mean number of CR participants enrolled/mo declined during the pandemic (-10%; 33.8 +/- 2.0 vs 30.5 +/- 3.2, P = .39), the mean cost/participant increased marginally (+13%; $2897 +/- $131 vs $3265 +/- $149, P = .09), and the mean reimbursement/participant decreased slightly (-4%; $2959 +/- $224 vs $2844 +/- $181, P = .70). However, these differences did not reach statistical significance. The pre-COVID mean operating surplus/participant ($62 +/- $140) eroded into a deficit of -$421 +/- $170/participant during the pandemic. No known COVID-19 infections occurred among the 183 participants and 14 on-site staff members during the pandemic period. CONCLUSIONS: COVID-19-related safety protocols required CR programs to modify service delivery. Results demonstrate that it was possible to safely maintain this critically important service; however, CR program costs exceeded revenues. The challenge going forward is to optimize CR service delivery to increase participation and achieve financial solvency. |*COVID-19[MESH] |*Cardiac Rehabilitation/economics[MESH] |*Health Care Costs[MESH] |Aged[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Patient Safety[MESH]Financial Analysis of Cardiac Rehabilitation and the Impact of COVID-1(epmc).pdf DeepDyve Pubget Overpricing